MMP7 and idiopathic pulmonary fibrosis: Despite these favorable test characteristics, guidelines published in 2018 from the American Thoracic Society do not support measuring serum MMP7 to diagnose IPF because of concern about false negatives, which could limit patient access to life-prolonging therapies [5].